Why the study?
Does transfer for primary PCI reduce mortality compared to onsite fibrinolytic therapy in STEMI patients when accounting for PCI-related delays?
Does transfer for primary PCI reduce mortality compared to onsite fibrinolytic therapy in STEMI patients when accounting for PCI-related delays?
The mortality benefit of transferring STEMI patients for primary PCI over onsite fibrinolysis is highly time-dependent and is nullified when PCI-related delays reach approximately 120 minutes.
Answers are grounded in this paper and cite their sources.
Time-dependent benefit warrants delay-aware STEMI triage; leaves open precise cutoffs in contemporary systems.
PURPOSE OF REVIEW: For patients presenting with ST-elevation myocardial infarction (STEMI), primary percutaneous coronary intervention (PPCI) is superior to onsite fibrinolytic therapy (O-FT) when administered in a timely fashion. This benefit diminishes as PCI-related delay increases. This review examines recent data exploring this relationship, offering insight into possible mechanisms for the time-dependent benefit of PCI. RECENT FINDINGS: The advantage of transfer for primary PCI (X-PCI) over O-FT was analyzed in a contemporary propensity-score matched cohort by evaluating outcomes based on PCI-related delay (door-to-balloon time minus door-to-needle time). In 19 012 matched STEMI patients from the National Registry of Myocardial Infarction database, the delay to PCI wherein the mortality advantage for X-PCI was nullified compared with O-FT was approximately 120 min. Extensive delays were found to attenuate the mortality benefit of X-PCI [number needed to treat (NNT) 23 for PCI-related delay >60 min; NNT 44 for PCI-related delay 60-90 min; and NNT 250 for PCI-related delay >90 min]. SUMMARY: The benefit of PCI over O-FT appears to markedly decrease as PCI-related delay increases, particularly in the case of interhospital transfer, which can often lead to long reperfusion times. Various strategies can reduce PCI-related delays, including the establishment of STEMI systems of care and regionalization. Furthermore, alternate pharmacoinvasive strategies should be considered when significant delay to PCI is anticipated.
No takes yet. Share an insight, caveat, or question.
Chakrabarti et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: